US5540931A
(en)
*
|
1989-03-03 |
1996-07-30 |
Charles W. Hewitt |
Methods for inducing site-specific immunosuppression and compositions of site specific immunosuppressants
|
US4996193A
(en)
*
|
1989-03-03 |
1991-02-26 |
The Regents Of The University Of California |
Combined topical and systemic method of administration of cyclosporine
|
CA1340994C
(en)
*
|
1989-09-21 |
2000-05-16 |
Rudolf Edgar Dr. Falk |
Treatment of conditions and disease
|
ZA927277B
(en)
*
|
1991-10-02 |
1993-05-19 |
Boston Ocular Res |
Dry eye treatment process and solution.
|
DE69307505T2
(de)
|
1992-05-13 |
1997-07-24 |
Sandoz-Patent-Gmbh, 79539 Loerrach |
Opthalmische zusammensetzungen enthaltend ein cyclosporin
|
US5366739A
(en)
*
|
1992-08-06 |
1994-11-22 |
Deo Corporation |
Method of ophthalmic drug delivery
|
US5830508A
(en)
|
1992-08-06 |
1998-11-03 |
Deo Corporation |
Composition for treating dry eye
|
US5686436A
(en)
|
1993-05-13 |
1997-11-11 |
Hiv Diagnostics, Inc. |
Multi-faceted method to repress reproduction of latent viruses in humans and animals
|
US5474979A
(en)
*
|
1994-05-17 |
1995-12-12 |
Allergan, Inc. |
Nonirritating emulsions for sensitive tissue
|
IE75744B1
(en)
*
|
1995-04-03 |
1997-09-24 |
Elan Corp Plc |
Controlled release biodegradable micro- and nanospheres containing cyclosporin
|
US5869079A
(en)
*
|
1995-06-02 |
1999-02-09 |
Oculex Pharmaceuticals, Inc. |
Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
|
US5858401A
(en)
*
|
1996-01-22 |
1999-01-12 |
Sidmak Laboratories, Inc. |
Pharmaceutical composition for cyclosporines
|
DE69715382T2
(de)
|
1996-02-13 |
2003-04-30 |
G.D. Searle & Co., Chicago |
Arzneimittelkombinationen mit immunosuppressiven wirkungen welche cyclooxygenase-2 inhibitoren und leukotrien lta4 hydrase-inhibitoren enthalten
|
JP2000504723A
(ja)
|
1996-02-13 |
2000-04-18 |
ジー.ディー.サール アンド カンパニー |
シクロオキシゲナーゼ―2阻害剤および5―リポキシゲナーゼ阻害剤投与の免疫抑制効果
|
JP2000506170A
(ja)
*
|
1996-03-05 |
2000-05-23 |
メデイノックス,インコーポレイテッド |
酸化窒素スキャベンジャーを用いる複合治療方法とそのために有用な組成物
|
BR9811716A
(pt)
|
1997-10-08 |
2000-07-18 |
Isotechnika Inc |
Análogos de ciclosporina deuterados e o seu emprego como agentes de modulação imunológica
|
US20030220234A1
(en)
*
|
1998-11-02 |
2003-11-27 |
Selvaraj Naicker |
Deuterated cyclosporine analogs and their use as immunodulating agents
|
US6861411B1
(en)
|
1997-12-02 |
2005-03-01 |
Pfizer, Inc. |
Method of treating eye infections with azithromycin
|
US5981607A
(en)
*
|
1998-01-20 |
1999-11-09 |
Allergan |
Emulsion eye drop for alleviation of dry eye related symptoms in dry eye patients and/or contact lens wearers
|
GB9818278D0
(en)
*
|
1998-08-22 |
1998-10-14 |
Smith & Nephew |
Compositions
|
US6217895B1
(en)
|
1999-03-22 |
2001-04-17 |
Control Delivery Systems |
Method for treating and/or preventing retinal diseases with sustained release corticosteroids
|
US20040121014A1
(en)
*
|
1999-03-22 |
2004-06-24 |
Control Delivery Systems, Inc. |
Method for treating and/or preventing retinal diseases with sustained release corticosteroids
|
US6239113B1
(en)
|
1999-03-31 |
2001-05-29 |
Insite Vision, Incorporated |
Topical treatment or prevention of ocular infections
|
US7056893B2
(en)
|
1999-03-31 |
2006-06-06 |
Insite Vision, Inc. |
Topical treatment for prevention of ocular infections
|
US6255280B1
(en)
|
1999-04-08 |
2001-07-03 |
University Of Kentucky Research Foundation |
Protection against traumatic brain injury
|
US6254860B1
(en)
|
1999-04-13 |
2001-07-03 |
Allergan Sales, Inc. |
Ocular treatment using cyclosporin-A derivatives
|
DK1220849T3
(da)
|
1999-10-15 |
2004-09-27 |
Sucampo Ag |
Sammensætninger med bicykliske forbindelser og fremgangsmåde til stabilisering heraf
|
ES2206363T3
(es)
|
2000-04-07 |
2004-05-16 |
Laboratoire Medidom S.A. |
Formulaciones oftalmicas a base de ciclosporina, de acido hialuronico y de polisorbato.
|
US6375972B1
(en)
|
2000-04-26 |
2002-04-23 |
Control Delivery Systems, Inc. |
Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
|
US20030021816A1
(en)
*
|
2001-06-06 |
2003-01-30 |
Sewon Kang |
Compositions and methods for use against acne-induced inflammation and dermal matrix-degrading enzymes
|
KR101006206B1
(ko)
*
|
2001-10-19 |
2011-01-07 |
이소테크니카 인코포레이티드 |
시클로스포린 a 알데히드의 제조 방법
|
KR20030065831A
(ko)
*
|
2002-02-01 |
2003-08-09 |
주식회사 태평양 |
사이클로스포린을 함유한 지속 방출형 약학적 조성물
|
US8871241B2
(en)
*
|
2002-05-07 |
2014-10-28 |
Psivida Us, Inc. |
Injectable sustained release delivery devices
|
US6930127B2
(en)
*
|
2002-08-15 |
2005-08-16 |
Eaton Veterinary Laboratories, Inc. |
Veterinary treatment of ophthalmic disease in animals using topical tacrolimus
|
US7354574B2
(en)
|
2002-11-07 |
2008-04-08 |
Advanced Ocular Systems Limited |
Treatment of ocular disease
|
CA2518265A1
(en)
*
|
2003-03-17 |
2004-09-30 |
Albany Molecular Research, Inc. |
Novel cyclosporins
|
US20040185068A1
(en)
*
|
2003-03-18 |
2004-09-23 |
Zhi-Jian Yu |
Self-emulsifying compositions, methods of use and preparation
|
ES2665464T3
(es)
*
|
2003-03-28 |
2018-04-25 |
Sigmoid Pharma Limited |
Forma de dosificación oral sólida que contiene microcápsulas sin costuras
|
US7083802B2
(en)
|
2003-07-31 |
2006-08-01 |
Advanced Ocular Systems Limited |
Treatment of ocular disease
|
US20050059583A1
(en)
|
2003-09-15 |
2005-03-17 |
Allergan, Inc. |
Methods of providing therapeutic effects using cyclosporin components
|
US7087237B2
(en)
|
2003-09-19 |
2006-08-08 |
Advanced Ocular Systems Limited |
Ocular solutions
|
US7083803B2
(en)
|
2003-09-19 |
2006-08-01 |
Advanced Ocular Systems Limited |
Ocular solutions
|
AU2005209201B2
(en)
|
2004-01-20 |
2010-06-03 |
Allergan, Inc. |
Compositions for localized therapy of the eye, comprising preferably triamcinolone acetonide and hyaluronic acid
|
US7923471B2
(en)
*
|
2004-05-14 |
2011-04-12 |
Alcon, Inc. |
Method of treating dry eye disorders and uveitis
|
US20050277584A1
(en)
*
|
2004-06-09 |
2005-12-15 |
Allergan, Inc. |
Pharmaceutical compositions comprising cyclosporins
|
US20080020018A1
(en)
*
|
2004-09-27 |
2008-01-24 |
Joey Moodley |
Combination Products
|
US7511013B2
(en)
*
|
2004-09-29 |
2009-03-31 |
Amr Technology, Inc. |
Cyclosporin analogues and their pharmaceutical uses
|
US7378391B2
(en)
*
|
2004-09-29 |
2008-05-27 |
Amr Technology, Inc. |
Cyclosporin alkyne analogues and their pharmaceutical uses
|
US7361636B2
(en)
*
|
2004-10-06 |
2008-04-22 |
Amr Technology, Inc. |
Cyclosporin alkynes and their utility as pharmaceutical agents
|
US7135455B2
(en)
*
|
2004-11-15 |
2006-11-14 |
Allergan, Inc |
Methods for the therapeutic use of cyclosporine components
|
US7151085B2
(en)
*
|
2004-11-15 |
2006-12-19 |
Allergan, Inc. |
Therapeutic methods using cyclosporine components
|
US20060148686A1
(en)
*
|
2004-12-30 |
2006-07-06 |
Bausch & Lomb Incorporated |
Ophthalmic compositions comprising steroid and cyclosporine for dry eye therapy
|
JP4974903B2
(ja)
|
2005-02-09 |
2012-07-11 |
参天製薬株式会社 |
疾患または状態を処置するための液体処方物
|
WO2007011880A2
(en)
|
2005-07-18 |
2007-01-25 |
Minu, L.L.C. |
Enhanced ocular neuroprotection/neurostimulation
|
US20070014760A1
(en)
*
|
2005-07-18 |
2007-01-18 |
Peyman Gholam A |
Enhanced recovery following ocular surgery
|
US7745400B2
(en)
*
|
2005-10-14 |
2010-06-29 |
Gregg Feinerman |
Prevention and treatment of ocular side effects with a cyclosporin
|
US9839667B2
(en)
|
2005-10-14 |
2017-12-12 |
Allergan, Inc. |
Prevention and treatment of ocular side effects with a cyclosporin
|
AU2006304143A1
(en)
*
|
2005-10-14 |
2007-04-26 |
Allergan, Inc. |
Prevention and treatment of drug-associated ocular side effects with a cyclosporin
|
KR20080065704A
(ko)
*
|
2005-11-09 |
2008-07-14 |
콤비네이토릭스, 인코포레이티드 |
의학적 이상의 치료 방법들, 조성물들, 및 키트들
|
KR20140093764A
(ko)
|
2006-02-09 |
2014-07-28 |
산텐 세이야꾸 가부시키가이샤 |
안정한 제제와 그 제조 및 사용 방법
|
WO2007095486A1
(en)
*
|
2006-02-13 |
2007-08-23 |
Allergan, Inc. |
Methods of treating blepharospasm using cyclosporine components
|
US7557082B2
(en)
|
2006-03-03 |
2009-07-07 |
Allergan, Inc. |
Treatment with cyclosporin A
|
US20070219127A1
(en)
*
|
2006-03-20 |
2007-09-20 |
Walt John G |
Cyclosporin a compositions
|
CA2645488C
(en)
|
2006-03-23 |
2014-09-02 |
Macusight, Inc. |
Formulations comprising rapamycin and methods using same for vascular permeability-related diseases or conditions
|
US7696166B2
(en)
*
|
2006-03-28 |
2010-04-13 |
Albany Molecular Research, Inc. |
Use of cyclosporin alkyne/alkene analogues for preventing or treating viral-induced disorders
|
US7696165B2
(en)
*
|
2006-03-28 |
2010-04-13 |
Albany Molecular Research, Inc. |
Use of cyclosporin alkyne analogues for preventing or treating viral-induced disorders
|
US20080146497A1
(en)
*
|
2006-07-25 |
2008-06-19 |
Graham Richard S |
Cyclosporin Compositions
|
CA2683409A1
(en)
*
|
2007-04-04 |
2008-10-16 |
Sigmoid Pharma Limited |
A pharmaceutical composition of tacrolimus
|
RU2009144186A
(ru)
*
|
2007-05-04 |
2011-06-10 |
Аллерган, Инк. (Us) |
Применение циклоспоринов при лечении пациентов с интраокулярными линзами
|
US20090081277A1
(en)
*
|
2007-09-21 |
2009-03-26 |
Allergan, Inc. |
Pharmaceutical formulations and methods for treating ocular conditions
|
CN101918019B
(zh)
*
|
2007-10-08 |
2014-11-26 |
奥里尼亚制药有限公司 |
包含钙调神经磷酸酶抑制剂或mTOR抑制剂的眼科组合物
|
ITMI20080003A1
(it)
*
|
2008-01-02 |
2009-07-03 |
Alfredo Pulpito |
Composizioni per uso oftalmico
|
US20100010082A1
(en)
*
|
2008-07-09 |
2010-01-14 |
Aspreva International Ltd. |
Formulations for treating eye disorders
|
US9445975B2
(en)
*
|
2008-10-03 |
2016-09-20 |
Access Business Group International, Llc |
Composition and method for preparing stable unilamellar liposomal suspension
|
JP2012514644A
(ja)
|
2009-01-08 |
2012-06-28 |
アラーガン インコーポレイテッド |
爪成長の増進用シクロスポリン組成物
|
US20110009339A1
(en)
*
|
2009-04-14 |
2011-01-13 |
Allergan, Inc |
Method of treating blurred vision and other conditions of the eye with cyclosporin compositions
|
SG176145A1
(en)
|
2009-05-18 |
2011-12-29 |
Sigmoid Pharma Ltd |
Composition comprising oil drops
|
PT2437762T
(pt)
|
2009-06-05 |
2017-11-14 |
Allergan Inc |
Lágrimas artificiais e usos terapêuticos
|
WO2010144194A1
(en)
*
|
2009-06-09 |
2010-12-16 |
Lux Biosciences, Inc. |
Topical drug delivery systems for ophthalmic use
|
US9878036B2
(en)
|
2009-08-12 |
2018-01-30 |
Sigmoid Pharma Limited |
Immunomodulatory compositions comprising a polymer matrix and an oil phase
|
EP2335735A1
(de)
|
2009-12-14 |
2011-06-22 |
Novaliq GmbH |
Pharmazeutische Zusammensetzung zur Behandlung von trockenem Auge
|
EP2515864A4
(de)
*
|
2009-12-23 |
2013-09-11 |
Psivida Inc |
Vorrichtung mit verzögerter freisetzung
|
GB201020032D0
(en)
|
2010-11-25 |
2011-01-12 |
Sigmoid Pharma Ltd |
Composition
|
US8957048B2
(en)
|
2011-10-06 |
2015-02-17 |
Allergan, Inc. |
Compositions for the treatment of dry eye
|
RU2641963C2
(ru)
*
|
2011-11-15 |
2018-01-23 |
Аллерган, Инк. |
Взвеси циклоспорина а формы 2
|
ES2578154T3
(es)
|
2011-11-15 |
2016-07-21 |
Allergan, Inc. |
Forma 2 de ciclosporina y método para prepararla
|
KR102029513B1
(ko)
|
2011-11-15 |
2019-10-07 |
알러간, 인코포레이티드 |
사이클로스포린 제2형의 지속 작용 제형
|
US9907826B2
(en)
|
2011-12-07 |
2018-03-06 |
Allergan, Inc. |
Efficient lipid delivery to human tear film using a salt-sensitive emulsion system
|
US20130266615A1
(en)
*
|
2012-04-10 |
2013-10-10 |
Bin Wu |
Non-immunogenic delivery vehicle for beta-, gamma-, and delta-tocopherols and methods of using and making same
|
EP2844268A4
(de)
*
|
2012-04-20 |
2015-11-25 |
Univ Howard |
Verfahren zur behandlung einer augenkrankheit und zusammensetzungen zur behandlung einer augenkrankheit
|
GB201212010D0
(en)
|
2012-07-05 |
2012-08-22 |
Sigmoid Pharma Ltd |
Formulations
|
GB201319791D0
(en)
|
2013-11-08 |
2013-12-25 |
Sigmoid Pharma Ltd |
Formulations
|
EP3881829A1
(de)
|
2014-11-07 |
2021-09-22 |
Sublimity Therapeutics Limited |
Cyclosporin enthaltende zusammensetzungen
|
US10279005B2
(en)
|
2014-11-25 |
2019-05-07 |
Allergan, Inc. |
Stabilized omega-3 ophthalmic compositions
|
US9820954B2
(en)
|
2015-08-19 |
2017-11-21 |
Jenivision Inc. |
Quantitative peri-orbital application of ophthalmology drugs
|
US20190224275A1
(en)
|
2017-05-12 |
2019-07-25 |
Aurinia Pharmaceuticals Inc. |
Protocol for treatment of lupus nephritis
|